Recent advances in understanding the role of hypoxia-inducible factor 1α in renal fibrosis

Int Urol Nephrol. 2020 Jul;52(7):1287-1295. doi: 10.1007/s11255-020-02474-2. Epub 2020 May 6.

Abstract

Renal fibrosis is the most common pathological manifestation of chronic kidney disease (CKD), and with numerous influencing factors, its pathogenesis is complex. Epithelial-mesenchymal transition (EMT) is known to promote the progression of renal fibrosis via alterations in the secreted proteome. Moreover, blocking or even reversing EMT can effectively reduce the degree of fibrosis. As such, targeting the key molecules responsible for promoting EMT may be an effective strategy for inhibiting renal fibrosis. Research in recent years has demonstrated that hypoxia-inducible factor 1α (HIF-1α) acts to promote renal fibrosis through regulation of EMT. However, the relationship between HIF-1α and EMT remains incompletely understood. In the present review, the underlying mechanism of the interaction between HIF-1α and EMT is explored to provide novel insight into the pathogenesis of renal fibrosis and new ideas for early targeted intervention.

Keywords: Epithelial–mesenchymal transition; Hypoxia; Hypoxia-inducible factor-1α; Renal fibrosis.

Publication types

  • Review

MeSH terms

  • Epithelial-Mesenchymal Transition / physiology*
  • Fibrosis / etiology
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / physiology*
  • Kidney / pathology*
  • Kidney Diseases / etiology*

Substances

  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit